Related Experiment Videos
The eosinophil and its role in asthma
1Department of Physiology and Pharmacology, University of Southampton, Hampshire, UK.
General Pharmacology
|June 1, 1996
Summary
Eosinophils, key in parasitic defense and asthma, release mediators causing lung inflammation. Current asthma treatments focus on anti-inflammatory drugs like inhaled corticosteroids.
Area of Science:
- Immunology
- Cell Biology
- Respiratory Medicine
Background:
- Eosinophils are crucial for host defense against parasitic infections.
- These cells also play a significant role in inflammatory disorders, including asthma.
- Eosinophils produce various pro-inflammatory and cytotoxic mediators.
Purpose of the Study:
- To elucidate the role of eosinophils in asthma pathogenesis.
- To understand the mechanisms of eosinophil recruitment and activation in the lung.
- To highlight the impact of eosinophil-derived mediators on lung inflammation and damage.
Main Methods:
- The study reviews the biological functions and inflammatory roles of eosinophils.
- Mechanisms of eosinophil migration, activation, and survival are discussed.
- Current therapeutic strategies for asthma involving eosinophils are examined.
Main Results:
- Eosinophils are recruited to the lung during asthma exacerbations.
- Activation and prolonged survival are mediated by local inflammatory signals.
- Eosinophil mediators contribute to lung tissue damage and persistent inflammation.
Conclusions:
- Eosinophils are central players in asthma-related lung inflammation.
- Targeting eosinophil activity is a key strategy in asthma management.
- Effective therapies include inhaled corticosteroids and other anti-inflammatory agents.